Government Affairs
Refine Search
Pharmaceutical
Canada’s Minister of Public Services and Procurement Anita Anand yesterday announced that the government has signed agreements with France’s Sanofi and UK-based GlaxoSmithKline to secure up to 72 million doses of their COVID-19 adjuvanted recombinant protein-based vaccine candidate. 23 September 2020
Pharmaceutical
Vaccine makers, and the biopharmaceutical industry more generally, are encouraged to see the broad international support the COVAX Facility has received. 22 September 2020
Pharmaceutical
The European Parliament at yesterday’s Plenary session called for the European Union to be more self-sufficient when it comes to medicines and medical equipment so that affordable treatments are available at any time. 18 September 2020
Biotechnology
German company BioNTech was trading 2% higher in early trading on Tuesday. 15 September 2020
Pharmaceutical
Never one to miss the chance for a spot of one-upmanship on its rivals, the Putin administration has boasted of the rapid rate of participants signing up to dose up on the Sputnik V vaccine for COVID-19. 15 September 2020
Biotechnology
Valneva has announced a partnership with USA-based Dynavax Technologies for the supply of Dynavax' CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001 14 September 2020
Pharmaceutical
The USA’s National Institutes of Health (NIH) has launched two of three adaptive Phase III clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. 12 September 2020
Pharmaceutical
The UK has secured a free trade agreement with Japan, which is the UK’s first major trade deal as an independent trading nation and will increase trade with Japan by an estimated £15.2 billion ($19.4 billion), the UK Department of International Trade announced today, and which Trade Secretary Liz Truss called “a historic moment for the UK and Japan as our first major post-Brexit trade deal.” 11 September 2020
Pharmaceutical
Adding to a similar deal with Mexico earlier this week, the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, an signed a cooperation agreement with Brazil’s State of Bahia, to supply up to 50 million doses of the Russian COVID-19 vaccine Sputnik V, the world's first registered coronavirus vaccine. 11 September 2020
Pharmaceutical
A group of health activists, including Ranbaxy whistle blower Dinesh Thakur, have petitioned India's Ministry of Health and Family Welfare to ensure greater transparency in regulation, especially over clinical trials. 9 September 2020
Biotechnology
Australian biotech CSL Limited today revealed it has signed a heads of agreement (HoA) with the Australian government for the supply of 51 million doses of the University of Queensland’s (UQ) COVID-19 vaccine candidate (V451), and a separate HoA with UK-based AstraZeneca to manufacture the Oxford University candidate (AZD1222), should clinical trials of both prove successful. 7 September 2020
Pharmaceutical
The US Centers for Medicare & Medicaid Services (CMS) last week finalized a rule that would significantly toughen the penalty if hospitals fail to comply with the price-transparency mandate, which takes effect on January 1, 2021. 7 September 2020
Biotechnology
Shares of US drugmaker AbbVie closed down 3.4% at $92.24 yesterday, after it was revealed that US House Committee on Oversight and Government Reform chairwoman Carolyn Maloney intends to subpoena AbbVie for documents related to the committee's investigation into how big-name drugmakers price some of the world's best-selling drugs. 2 September 2020
Pharmaceutical
Last week’s notable news included Vertex Pharmaceuticals receiving earlier-than-expected approval in Europe for its Kaftrio plus ivacaftor for multiple sclerosis. Also scoring European approval last week was GlaxoSmithKline’s Blenrep for multiple myeloma. The authorization by US President Donald Trump administration, via the Food and Drug Administration, of emergency use for convalescent plasma to treat COVID-19 patients has raised questions on the agency’s credibility. On the M&A front, Yumanity Therapeutics announced it is merging with Proteostasis, to leverage protein misfolding to advance programs for neurodegenerative diseases, including Yumanity’s Parkinson’s disease candidate YTX-7739. 30 August 2020
Pharmaceutical
Although there is no assurance that an acceptably safe and effective vaccine against COVID-19 will be developed this side of the UK’s final Brexit on December 31, the British medicines regulator has announced a raft of measures for approving such a product without waiting for a decision from the European Medicines Agency. 29 August 2020
Pharmaceutical
When Russia chose to approve the Moscow-developed Sputnik V vaccine for COVID-19 this month, more than a few eyebrows were raised in the western world, in particular due to the absence of Phase III data. 28 August 2020
Pharmaceutical
The European Commission (EC) has signed a contract with Anglo-Swedish pharma major AstraZeneca around the company’s AZD1222 COVID-19 vaccine candidate. 28 August 2020
Biotechnology
US biotech Moderna has concluded advanced exploratory talks with the European Commission (EC) to supply 80 million doses of mRNA-1273, its vaccine candidate against COVID-19. 24 August 2020
Pharmaceutical
Given the lack of Phase III data, it is not surprising that some international media reports reacted with skepticism to Russia’s approval of the so-called Sputnik V vaccine for COVID-19 last week. 20 August 2020
Pharmaceutical
US drug distributor McKesson Corporation closed 4% up on Friday following a major announcement. 17 August 2020
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze